Regeneron logo

Regeneron

17326 employees · est. 1988 · Tarrytown, United States

VS
Ring Therapeutics logo

Ring Therapeutics

Founded by Flagship Pioneering, Ring is pioneering a new class of targeted medicines that delivers more.

45 employees · est. 2017 · Cambridge, United States

Regeneron is the older company (1988 vs 2017); Regeneron is the larger of the two.

Side-by-Side Comparison

Regeneron Ring Therapeutics
Founded
1988 older 2017
Headquarters
Tarrytown, United States Cambridge, United States
Employees
17326 larger 45
Industry
Biopharma, Biotechnology, Pharmaceutical Biotechnology, Health Care, Health and Wellness
Funding Stage
Post Ipo Equity Series C
Total Funding
Not tracked yet $253.50M
Funding Rounds
Not tracked yet 3
Services
Research and Development, Clinical Trials Management, Biologic Drug Development, Genetic Therapy Solutions, Scientific Publications Engineering vector-based therapies, Developing vector conjugate therapies, Drug design and manufacturing platform
Target Customers
Patients with Serious Diseases, Healthcare Providers, Scientific Community, Investors, Medical Researchers Pharmaceutical Companies, Biotechnology Researchers, Healthcare Providers, Patients with Unmet Medical Needs
Taxonomy
Not tracked yet Gene Therapy, Targeted Medicines, Anellovector Therapeutics, Virome Biology, Redosable Gene Therapy, Targetable Gene Therapy, Multi-product Platform, Therapeutic Modalities, Disease Treatment Expansion, Biotechnology Innovation, Flagship Pioneering, Ring Therapeutics Platform, Commensal Microorganisms, Beyond Gene Replacement, Biopharmaceuticals Development
Website
regeneron.com ringtx.com
Regeneron logo

About Regeneron

Regeneron, founded in 1988, operates at the forefront of the Biopharma, Biotechnology, and Pharmaceutical industries. This United States-based company has carved out a robust niche in the development and commercialization of life-transforming medicines for individuals afflicted with serious diseases...

Ring Therapeutics logo

About Ring Therapeutics

Ring Therapeutics, founded by Flagship Pioneering in 2017, is at the forefront of developing a new class of targeted medicines. With a clear mission to pioneer advanced pharmaceutical solutions, the company is positioned within the Biotechnology, Health Care, Health and Wellness, and Pharmaceutical...

We will tell you when either one moves

BounceWatch watches Regeneron and Ring Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Regeneron and Ring Therapeutics — by email.

Frequently Asked Questions

Regeneron. Ring Therapeutics — Founded by Flagship Pioneering, Ring is pioneering a new class of targeted medicines that delivers more.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Regeneron has raised undisclosed funding while Ring Therapeutics has raised $253.50M.
Regeneron and Ring Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Regeneron with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Regeneron on 22 Jun 2026, and Ring Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy